Kattner, S., Müller, J., Glanz, K., Manoochehri, M., Sylvester, C., Vainshtein, Y., . . . Sohn, K. (2023). Identification of two early blood biomarkers ACHE and CLEC12A for improved risk stratification of critically ill COVID-19 patients. Scientific Reports, 13(1), 1. https://doi.org/10.1038/s41598-023-30158-1
Chicago Style (17th ed.) CitationKattner, Simone, Jan Müller, Karolina Glanz, Mehdi Manoochehri, Caroline Sylvester, Yevhen Vainshtein, Marc Moritz Berger, Thorsten Brenner, and Kai Sohn. "Identification of Two Early Blood Biomarkers ACHE and CLEC12A for Improved Risk Stratification of Critically Ill COVID-19 Patients." Scientific Reports 13, no. 1 (2023): 1. https://doi.org/10.1038/s41598-023-30158-1.
MLA (9th ed.) CitationKattner, Simone, et al. "Identification of Two Early Blood Biomarkers ACHE and CLEC12A for Improved Risk Stratification of Critically Ill COVID-19 Patients." Scientific Reports, vol. 13, no. 1, 2023, p. 1, https://doi.org/10.1038/s41598-023-30158-1.